Thinking of quitting a GLP-1? A physician outlines six risks, from weight regain and muscle loss to worsening biomarkers and mental health consequences.
Read at Fox News ↗ Archived copy (Wayback) ↗
Banana News stores headlines, short snippets and links only. Archived 2026-11-12T13:10:34Z (origin: Live feed).
Story timeline & what changed → 🐇 Rabbit hole ⏳ Time Machine
Sentences the outlets themselves published, word for word, each with its source. Banana News does not write or summarise.
2 outlets with a stated political placement. Shows who is covering this, not whether it is biased. Where placements come from. Placements are Banana News editorial judgments, not statistical measures; tell us if you disagree.
No coverage found in our feeds.
No coverage found in our feeds.
Ozempic and Zepbound users face 6 rebound risks after stopping, doctor warns
Fox News
GLP-1 users face 6 rebound risks after stopping the weight-loss drugs
New York Post
Placements are outlet-level and only shown where an openly licensed source states one - see About.
Placements are Banana News editorial judgments, not statistical measures; tell us if you disagree.
🔒 Corroboration and first-report numbers: Bunch and up
Sources: Wikidata (CC0), Wikipedia perennial sources list (CC BY-SA 4.0) and our own statistics. How we build this
While GLP-1 medications like Ozempic, Wegovy and Zepbound have reshaped weight management and diabetes control, research shows that many patients stop taking them within a year.
Liked this? Send a small tip in Banana Coin (BNNA) from your own wallet on Base. It's a thank-you only - no perks.
You need a wallet app that holds BNNA on Base (for example Coinbase Wallet). Tap an amount, then confirm in the wallet.
Experimental coin, not financial advice. On-chain transfers are final. We never ask for your recovery phrase.
